ABSTRACT
La tendinitis calcificante prevertebral es una causa poco frecuente de cervicalgia aguda, caracterizada por la identificación de calcificaciones a nivel de C1-C2 y, la presencia de una colección líquida en el espacio prevertebral, que ocasiona un desplazamiento de la línea radiográfica prevertebral en los estudios de imagen. Resulta de gran importancia identificar esta rara entidad, benigna y autolimitada, y no confundirla con otros procesos que erróneamente propiciasen actitudes terapéuticas inadecuadas (AU)
Prevertebral calcific tendinitis is an uncommon cause of acute neck pain characterized by the identification of calcifications at C1-C2 level and the presence of a liquid collection at the prevertebral space which causes the displacement of the prevertebral radiographic line in imaging studies. It is very important to identify this rare, benign and self-limiting pathology, in order not to confuse it with other diseases that could erroneously lead to inappropriate treatment (AU)
Subject(s)
Humans , Female , Middle Aged , Tendinopathy/diagnosis , Tendinopathy/therapy , Neck Pain/complications , Neck Pain/etiology , Cervical Atlas/pathology , Cervical Atlas , Tendinopathy/physiopathology , Tendinopathy , Cervical Atlas/physiopathologyABSTRACT
Prevertebral calcific tendinitis is an uncommon cause of acute neck pain characterized by the identification of calcifications at C1-C2 level and the presence of a liquid collection at the prevertebral space which causes the displacement of the prevertebral radiographic line in imaging studies. It is very important to identify this rare, benign and self-limiting pathology, in order not to confuse it with other diseases that could erroneously lead to inappropriate treatment.
Subject(s)
Calcinosis/diagnosis , Neck Pain/etiology , Tendinopathy/diagnosis , Acute Disease , Calcinosis/complications , Female , Humans , Middle Aged , Tendinopathy/complicationsABSTRACT
Introducción: La PEG es una técnica poco agresiva y con escasas complicaciones. Estas características la han convertido en la vía de elección para nutrir a los pacientes que requieren apoyo nutricional por periodos prolongados. Objetivos: Conocer la evolución y calidad de vida de pacientes y cuidadores con nutrición mediante PEG. Métodos: Estudio retrospectivo de pacientes con PEG en un hospital comarcal desde julio de 1998 a julio de2009. Se revisaron los registros hospitalarios y se contacto telefónicamente con los pacientes. Resultados: Se registraron 299 pacientes con PEG Se observó un incremento progresivo de su uso para el tratamiento nutricional. 152 (50,8%). fueron varones La edad fue 73,62 ± 13,05 años, siendo los varones más jóvenes que las mujeres (t = 5,07; p < 0,001). La indicación más frecuente para el uso de la PEG fue la patología neurológica 222 (85,7%). La duración del tratamiento nutricional fue de 390 días (Rango 1-2.913) mostrándose independiente del resto de variables. La finalización del tratamiento fue por: fallecimiento 134 (93,1%), recuperando la vía oral 10 (6,9%) pacientes. La calidad de vida mejoró significativamente tanto en los pacientes (Z = -6,59; p < 0,001)como en los cuidadores (Z = -6,83; p < 0,001) después de la PEG. Conclusiones: Existe un incremento progresivo en el uso de la PEG con un tiempo medio de tratamiento mayor a un año, finalizándose en la mayoría de los pacientes con el fallecimiento. La calidad de vida experimenta una mejoría después de la PEG tanto en los pacientes como en los cuidadores de esta serie (AU)
Introduction: The PEG is shown as a technique rather aggressive and with few complications. These characteristics have become the route of choice for enteral nutrition in patients who require nutritional support for prolonged periods. Objectives: To know the evolution and quality of life of patients and caregivers with nutrition through PEG.Methods: Retrospective study of patients with PEG ina district hospital from July 1998 to July 2009. Were viewed hospital records and telephone contact with patients Results: There were 299 patients with PEG during the study period. There was a gradual increase in its use for nutritional therapy. Males were 152 (50.8%). There were152 (50,8%) males. The age was 73.62 ± 13,05 years,males being the youngest (t = 5.07, P < 0.001). The most frequent indication was neurological disease 222(85.7%). The duration of nutrition therapy was 390 days(range 1-2,913) showing independent from the rest of the variables. The completion of treatment was on death 134(93.1%) or recovering the mouth 10 (6.9%). The QL was significantly improved in both patients (Z = -6.59, P <0.001) and caregivers (Z = -6.83, P < 0.001) after PEG. Conclusions: There is a progressive increase in the use of PEG. with the mean time of treatment greater than one year, and being complete in most patients with the death.The quality of life experienced an improvement after PEG in both patients and caregivers in this series (AU)
Subject(s)
Humans , Parenteral Nutrition/methods , Gastrostomy/methods , Endoscopy, Gastrointestinal/methods , Retrospective Studies , Nutritional Support/statistics & numerical dataABSTRACT
INTRODUCTION: The PEG is shown as a technique rather aggressive and with few complications. These characteristics have become the route of choice for enteral nutrition in patients who require nutritional support for prolonged periods. OBJECTIVES: To know the evolution and quality of life of patients and caregivers with nutrition through PEG. METHODS: Retrospective study of patients with PEG in a district hospital from July 1998 to July 2009. We reviewed hospital records and telephone contact with patients. RESULTS: There were 299 patients with PEG during the study period. There was a gradual increase in its use for nutritional therapy. Males were 152 (50.8%). There were 152 (50,8%) males. The age was 73.62 ± 13,05 years, males being the youngest (t = 5.07, P < 0.001). The most frequent indication was "neurological disease" 222 (85.7%). The duration of nutrition therapy was 390 days (range 1-2,913) showing independent from the rest of the variables. The completion of treatment was on death 134 (93.1%) or recovering the mouth 10 (6.9%). The QL was significantly improved in both patients (Z = -6.59, p < 0.001) and caregivers (Z = -6.83, P < 0.001) after PEG. CONCLUSIONS: There is a progressive increase in the use of PEG. with the mean time of treatment greater than one year, and being complete in most patients with the death. The quality of life experienced an improvement after PEG in both patients and caregivers in this series.
